Samuel Corless

Samuel Corless

Auto-generated profile, based on publicly available information

Samuel Corless

University of Edinburgh 1 Wellcome Centre for Cell Biology Edinburgh, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
FSFernanda Cisneros Soberanis
Fernanda Cisneros Soberanis
ESEva L. Simpson
Eva L. Simpson
ABAlison Beckett
Alison Beckett
NPNina Pucekova
Nina Pucekova
SCSamuel Corless
Samuel Corless
WEWilliam C. Earnshaw
William C. Earnshaw
Chromosome compaction is a key feature of mitosis and critical for accurate chromosome segregation. However, a precise quantitative analysis of chromosome geometry during mitotic progression is lacking. Here, we use volume electron microscopy to map, with nanometer precision, chromosomes from prometaphase through telophase in human RPE1 cells. During prometaphase, chromosomes acquire a smoother surface, their arms shorten, and the primary centromeric constriction is formed. The chromatin is progressively compacted, ultimately reaching a remarkable nucleosome concentration of over 750 µM in late prometaphase that remains relatively constant during metaphase and early anaphase. Surprisingly, chromosomes then increase their volume in late anaphase prior to deposition of the nuclear envelope. The plateau of total chromosome volume from late prometaphase through early anaphase described here is consistent with proposals that the final stages of chromatin condensation in mitosis involve a limit density, such as might be expected for a process involving phase separation.

15 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SCSamuel Corless
Samuel Corless
NPNoor Pratap-Singh
Noor Pratap-Singh
NBNezha S. Benabdallah
Nezha S. Benabdallah
JBJasmin Boehm
Jasmin Boehm
ASAlexander M. Simon
Alexander M. Simon
SESylvia Erhardt
Sylvia Erhardt
Centromeres are the position on each chromosome that orchestrates the accurate partitioning of the genome during cell division. Centromere-dependent cell-cycle checkpoints are maintained by cancer cells to prevent catastrophic chromosome segregation defects in dividing cells 1, 2 , making centromeric chromatin a valuable target for anti-cancer therapeutics. However, no compounds have been identified that specifically target centromeric chromatin using standard drug discovery approaches. Here we develop a big-data approach to identify the protein composition of repetitive DNA loci, including centromeres, and screen candidate small molecules that act on centromeric chromatin composition. We discover that the BET bromodomain protein BRD4 localises to centromeres and regulates centromeric cohesion. We further show that the bromodomain inhibitor JQ1 affects centromeric BRD4 by stabilising a direct interaction between BRD4 and Centromere Protein B (CENP-B), acting as a molecular-glue that promotes centromere cohesion in a CENP-B-dependent manner. Strikingly, CENP-B transitions from a non-essential protein in JQ1-sensitive cells to the most significant determinant of cell-proliferation in JQ1-resistant cells. Our observations demonstrate a completely overlooked role for BRD4 and JQ1 in directly targeting the centromere, with important consequences for JQ1-derivatives currently entering clinical use 3 .